| scholarly article | Q13442814 |
| P50 | author | Yaodong Zhao | Q56747840 |
| P2093 | author name string | Chong DI | |
| P2860 | cites work | Cancer stem cells and drug resistance: the potential of nanomedicine | Q26998993 |
| Stem cells, cancer, and cancer stem cells | Q27860878 | ||
| Transitions between epithelial and mesenchymal states: acquisition of malignant and stem cell traits | Q28237197 | ||
| Identification of selective inhibitors of cancer stem cells by high-throughput screening | Q28255115 | ||
| Cancer stem cells: mirage or reality? | Q28257690 | ||
| Pharmacological profiling of disulfiram using human tumor cell lines and human tumor cells from patients | Q28267360 | ||
| Paclitaxel-carboplatin alone or with bevacizumab for non-small-cell lung cancer | Q28278736 | ||
| Epithelial-mesenchymal transition: at the crossroads of development and tumor metastasis | Q28283104 | ||
| Hypoxia--a key regulatory factor in tumour growth | Q29547318 | ||
| A perivascular niche for brain tumor stem cells | Q29614276 | ||
| CD117 and Stro-1 identify osteosarcoma tumor-initiating cells associated with metastasis and drug resistance | Q42014961 | ||
| Gamma-secretase inhibitors target tumor-initiating cells in a mouse model of ERBB2 breast cancer | Q42732429 | ||
| Randomized phase II trial of All-trans-retinoic acid with chemotherapy based on paclitaxel and cisplatin as first-line treatment in patients with advanced non-small-cell lung cancer. | Q43023367 | ||
| ABC transporters in cancer: more than just drug efflux pumps. | Q43193922 | ||
| Potent and specific inhibition of the breast cancer resistance protein multidrug transporter in vitro and in mouse intestine by a novel analogue of fumitremorgin C. | Q44245530 | ||
| Expression, up-regulation, and transport activity of the multidrug-resistance protein Abcg2 at the mouse blood-brain barrier. | Q44883138 | ||
| ABCG2 is related with the grade of glioma and resistance to mitoxantone, a chemotherapeutic drug for glioma | Q46064581 | ||
| Potentiation of cyclophosphamide chemotherapy using the anti-angiogenic drug thalidomide: importance of optimal scheduling to exploit the 'normalization' window of the tumor vasculature | Q46904006 | ||
| Mouse myeloma tumor stem cells: a primary cell culture assay | Q70590818 | ||
| The tumor microenvironment controls drug sensitivity | Q84952640 | ||
| Mechanisms of cancer drug resistance | Q29615849 | ||
| EMT, cancer stem cells and drug resistance: an emerging axis of evil in the war on cancer | Q29616360 | ||
| Wnt activity defines colon cancer stem cells and is regulated by the microenvironment | Q29618024 | ||
| Analysis of ABCG2 expression and side population identifies intrinsic drug efflux in the HCC cell line MHCC-97L and its modulation by Akt signaling | Q33372309 | ||
| Biologic characteristics of the side population of human small cell lung cancer cell line H446. | Q33535519 | ||
| Ovarian cancer stem-like side-population cells are tumourigenic and chemoresistant | Q33547790 | ||
| Sulforaphane, a dietary component of broccoli/broccoli sprouts, inhibits breast cancer stem cells | Q33820656 | ||
| Arsenic-specific stem cell selection during malignant transformation | Q33828693 | ||
| Sonic hedgehog pathway is essential for maintenance of cancer stem-like cells in human gastric cancer | Q33843343 | ||
| NOTCH pathway blockade depletes CD133-positive glioblastoma cells and inhibits growth of tumor neurospheres and xenografts | Q33883897 | ||
| Implication of microRNAs in drug resistance for designing novel cancer therapy | Q33903223 | ||
| Targeting Hedgehog--a cancer stem cell pathway | Q33925257 | ||
| Hedgehog signaling antagonist GDC-0449 (Vismodegib) inhibits pancreatic cancer stem cell characteristics: molecular mechanisms | Q34075584 | ||
| The intestinal stem cell signature identifies colorectal cancer stem cells and predicts disease relapse | Q34171959 | ||
| Targeting breast stem cells with the cancer preventive compounds curcumin and piperine | Q34574742 | ||
| Differentiation of a highly tumorigenic basal cell compartment in urothelial carcinoma. | Q34698294 | ||
| Epithelial-mesenchymal transition in cancer metastasis: mechanisms, markers and strategies to overcome drug resistance in the clinic | Q34967289 | ||
| Aldehyde dehydrogenase 1 is a putative marker for cancer stem cells in head and neck squamous cancer. | Q34981591 | ||
| Metformin: an emerging new therapeutic option for targeting cancer stem cells and metastasis | Q36026661 | ||
| Inhibition of sonic hedgehog pathway and pluripotency maintaining factors regulate human pancreatic cancer stem cell characteristics | Q36344857 | ||
| Pathophysiologic effects of vascular-targeting agents and the implications for combination with conventional therapies. | Q36688029 | ||
| Assessing current therapeutic approaches to decode potential resistance mechanisms in glioblastomas | Q36695514 | ||
| The leukemic stem cell niche: current concepts and therapeutic opportunities | Q37295129 | ||
| Multiple myeloma bone marrow niche | Q37438313 | ||
| Targeting Wnt signaling: can we safely eradicate cancer stem cells? | Q37763415 | ||
| The role of human aldehyde dehydrogenase in normal and cancer stem cells | Q37811959 | ||
| Targeting pancreatic cancer stem cells for cancer therapy | Q38021230 | ||
| The role of aldehyde dehydrogenase (ALDH) in cancer drug resistance. | Q38110652 | ||
| Inhibition of aldehyde dehydrogenase (ALDH) activity reduces chemotherapy and radiation resistance of stem-like ALDHhiCD44⁺ human breast cancer cells | Q39494709 | ||
| Mammosphere-forming cells from breast cancer cell lines as a tool for the identification of CSC-like- and early progenitor-targeting drugs | Q39687805 | ||
| The cancer stem cell selective inhibitor salinomycin is a p-glycoprotein inhibitor. | Q39707343 | ||
| Dibenzocyclooctadiene lignans overcome drug resistance in lung cancer cells--study of structure-activity relationship. | Q39837251 | ||
| Leukemic cells create bone marrow niches that disrupt the behavior of normal hematopoietic progenitor cells | Q39903574 | ||
| Podoplanin, a novel marker of tumor-initiating cells in human squamous cell carcinoma A431. | Q39974123 | ||
| Reversal of P-glycoprotein-mediated multidrug resistance of cancer cells by five schizandrins isolated from the Chinese herb Fructus Schizandrae | Q40013830 | ||
| Identification of cancer stem cell-like side population cells in human nasopharyngeal carcinoma cell line | Q40144546 | ||
| Circumvention of multi-drug resistance of cancer cells by Chinese herbal medicines | Q41970695 | ||
| P433 | issue | 2 | |
| P921 | main subject | multiple drug resistance | Q643839 |
| drug resistance | Q12147416 | ||
| P304 | page(s) | 289-293 | |
| P577 | publication date | 2014-12-16 | |
| P1433 | published in | Experimental and Therapeutic Medicine | Q23979083 |
| P1476 | title | Multiple drug resistance due to resistance to stem cells and stem cell treatment progress in cancer (Review) | |
| P478 | volume | 9 |
| Q38806608 | ABC gene expression profiles have clinical importance and possibly form a new hallmark of cancer. |
| Q58798114 | ATP-binding cassette transporters in progression and clinical outcome of pancreatic cancer: What is the way forward? |
| Q33577847 | Anticancer properties of a defensin like class IId bacteriocin Laterosporulin10. |
| Q58697956 | CD44/CD44v6 a Reliable Companion in Cancer-Initiating Cell Maintenance and Tumor Progression |
| Q26740207 | Cancer Stem Cell Quiescence and Plasticity as Major Challenges in Cancer Therapy |
| Q26747518 | Cancer Stem Cells: The Potential Targets of Chinese Medicines and Their Active Compounds |
| Q38601789 | Cancer stem cells in human digestive tract malignancies |
| Q58696999 | Chalcones Repressed the AURKA and MDR Proteins Involved in Metastasis and Multiple Drug Resistance in Breast Cancer Cell Lines |
| Q53681639 | Chemopreventive activity of celastrol in drug-resistant human colon carcinoma cell cultures. |
| Q37688612 | Different growth and metastatic phenotypes associated with a cell-intrinsic change of Met in metastatic melanoma |
| Q26865791 | Do relevant markers of cancer stem cells CD133 and Nestin indicate a poor prognosis in glioma patients? A systematic review and meta-analysis |
| Q36983775 | Ionizing radiation promotes advanced malignant traits in nasopharyngeal carcinoma via activation of epithelial-mesenchymal transition and the cancer stem cell phenotype |
| Q33598812 | Isolation, culture and identification of human adipose-derived stem cells |
| Q97528841 | Low GAS5 expression may predict poor survival and cisplatin resistance in cervical cancer |
| Q104064807 | MSC-induced lncRNA AGAP2-AS1 promotes stemness and trastuzumab resistance through regulating CPT1 expression and fatty acid oxidation in breast cancer |
| Q38712909 | Notch signaling plays a crucial role in cancer stem-like cells maintaining stemness and mediating chemotaxis in renal cell carcinoma |
| Q59792014 | Nutritional stress reprograms dedifferention in glioblastoma multiforme driven by PTEN/Wnt/Hedgehog axis: a stochastic model of cancer stem cells |
| Q42317546 | Quantitative assessment of CD44 genetic variants and cancer susceptibility in Asians: a meta-analysis |
| Q37625726 | Relevance of mortalin to cancer cell stemness and cancer therapy. |
| Q88912717 | Salvianolic acid B reverses multidrug resistance in nude mice bearing human colon cancer stem cells |
| Q64113617 | TARBP2-mediated destabilization of Nanog overcomes sorafenib resistance in hepatocellular carcinoma |
| Q38708140 | Targeting BCRP/ABCG2 by RNA interference enhances the chemotherapy sensitivity of human colon cancer side population cells |
| Q47101382 | The polycomb group protein BMI-1 inhibitor PTC-209 is a potent anti-myeloma agent alone or in combination with epigenetic inhibitors targeting EZH2 and the BET bromodomains |
Search more.